Generic-drug makers colluded to inflate prices, lawsuit says - Los Angeles Times

Representatives of some of the nation's largest generic-drug manufacturers used code words to collude with competitors to divvy up market share and coordinate price increases, according to a federal lawsuit.
Representatives of some of the nation's largest generic-drug manufacturers used code words to collude with competitors, according to a federal lawsuit.

Coronavirus Watch: Governments Rush to Secure Ventilators, 2020-03-16

Op-Ed: Prevent a legal catch-22 that could push thousands of generic drugs off the market - Los Angeles Times

U.S. states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit

U.S. Consumers Overpay for Generic Drugs – USC Schaeffer

The Status of California's Pay-for-Delay Legislation & Litigation - Food and Drug Law Institute (FDLI)

Drugmakers could find sympathetic US Supreme Court in drug pricing lawsuits

As CMS drug pricing data remains missing, 46brooklyn finds solace in deflating generic drug costs — 46brooklyn Research

Are We at the Dawn of “Insulin Socialism”?

Pay for Delay: Big Pharma's Most Maddening Business Tactic - The Atlantic

PDF) Earning Exclusivity: Generic Drug Incentives and the Hatch-Waxman Act

Bottle Of Lies - The Inside Story of The Generic Drug Boom by Manvika Jain - Issuu

Generic drug giants settle federal price-fixing charges - POLITICO